Stifel has decided to maintain its Buy rating of Revolution Medicines (NASDAQ:RVMD) and raise its price target from $37.00 to $47.00.
Shares of Revolution Medicines are trading up 0.2% over the last 24 hours, at $29.79 per share.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased